MDLZ
20
-4
NVDA
57
5
RSG
59
-3
PPG
62
-2
MS
64
-2
FCX
42
-5
WEC
50
-6
HAS
46
-3
SYK
62
-8
OI
41
2
CCI
21
-4
SRE
33
-17
NFLX
74
13
RL
79
3
PNR
63
-2
KR
42
-2
TXT
49
-6
GOOG
63
-2
EA
39
-5
FFIV
70
3
MDLZ
20
-4
NVDA
57
5
RSG
59
-3
PPG
62
-2
MS
64
-2
FCX
42
-5
WEC
50
-6
HAS
46
-3
SYK
62
-8
OI
41
2
CCI
21
-4
SRE
33
-17
NFLX
74
13
RL
79
3
PNR
63
-2
KR
42
-2
TXT
49
-6
GOOG
63
-2
EA
39
-5
FFIV
70
3
Financhill
Back

PureCycle Technologies Vs. Monopar Therapeutics Industry Stock Comparison

Sell
48

PCT
PureCycle Technologies

Last Price:
$9.73
Seasonality Move:
36.1%
Buy
73

MNPR
Monopar Therapeutics

Last Price:
$39.20
Seasonality Move:
-13.19%
Sell
48
PureCycle Technologies (PCT) is a Sell

Is PureCycle Technologies a Buy, Sell or Hold?

  • The current PureCycle Technologies [PCT] share price is $9.75. The Score for PCT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $39.32. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PCT Stock Price Chart

What is PureCycle Technologies's stock price today?

  • The PureCycle Technologies share price today is $9.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $39.32
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 40.52 Sell
Chaikin Money Flow: 1105202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.63 - 10.95) Sell
Bollinger Bands (100): (8.2 - 12.72) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.95 Buy
Relative Strength Index (14 RSI): 75.21 Buy
Chaikin Money Flow: 81027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.5 - 30.58) Buy
Bollinger Bands (100): (5.71 - 25.15) Buy

PCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.61 Buy
20-day SMA: 10.1 Sell
50-day SMA: 11.37 Sell
200-day SMA: 8.09 Buy
8-day EMA: 9.74 Buy
20-day EMA: 10.16 Sell
50-day EMA: 10.7 Sell
200-day EMA: 8.91 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.16 Buy
20-day SMA: 26.34 Buy
50-day SMA: 23.59 Buy
200-day SMA: 9.39 Buy
8-day EMA: 31.45 Buy
20-day EMA: 27.86 Buy
50-day EMA: 23.35 Buy
200-day EMA: 12.66 Buy

PureCycle Technologies Earnings Growth & PCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.11 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $2.41 per share.

PureCycle Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):